| Inferring tumour purity and stromal and immune cell admixture from expression data K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... Nature communications 4 (1), 1-11, 2013 | 1659 | 2013 |
| Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC deCarvalho, ... Cancer cell 32 (1), 42-56. e6, 2017 | 683* | 2017 |
| SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis R Aguirre-Gamboa, H Gomez-Rueda, E Martínez-Ledesma, ... PloS one 8 (9), e74250, 2013 | 523 | 2013 |
| Integrated genomic and molecular characterization of cervical cancer Cancer Genome Atlas Research Network Nature 543 (7645), 378, 2017 | 496 | 2017 |
| Systematic analysis of telomere length and somatic alterations in 31 cancer types FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ... Nature genetics 49 (3), 349-357, 2017 | 249 | 2017 |
| TumorFusions: an integrative resource for cancer-associated transcript fusions X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ... Nucleic acids research 46 (D1), D1144-D1149, 2018 | 105 | 2018 |
| Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer YL Deribe, Y Sun, C Terranova, F Khan, J Martinez-Ledesma, J Gay, ... Nature medicine 24 (7), 1047-1057, 2018 | 95* | 2018 |
| Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm E Martinez-Ledesma, RGW Verhaak, V Treviño Scientific reports 5 (1), 1-14, 2015 | 68 | 2015 |
| Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma X Hu, E Martinez-Ledesma, S Zheng, H Kim, F Barthel, T Jiang, KR Hess, ... Neuro-oncology 19 (6), 786-795, 2017 | 55 | 2017 |
| Systematic epigenomic analysis reveals chromatin states associated with melanoma progression P Fiziev, KC Akdemir, JP Miller, EZ Keung, NS Samant, S Sharma, ... Cell reports 19 (4), 875-889, 2017 | 55 | 2017 |
| Compact cancer biomarkers discovery using a swarm intelligence feature selection algorithm E Martinez, MM Alvarez, V Trevino Computational biology and chemistry 34 (4), 244-250, 2010 | 49 | 2010 |
| Buparlisib in patients with recurrent glioblastoma harboring phosphatidylinositol 3-kinase pathway activation: an open-label, multicenter, multi-arm, phase II trial PY Wen, M Touat, BM Alexander, IK Mellinghoff, S Ramkissoon, ... Journal of clinical oncology 37 (9), 741, 2019 | 48 | 2019 |
| Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects E Martínez, Y Kosuke, H Kim, GM Mills, V Treviño, V Roel GW Oncogene 34 (21), 2732-2740, 2015 | 43 | 2015 |
| Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions R Tamura, K Yoshihara, T Saito, R Ishimura, JE Martínez-Ledesma, H Xin, ... Oncogenesis 7 (1), 1-12, 2018 | 24 | 2018 |
| Comparative molecular life history of spontaneous canine and human gliomas SB Amin, KJ Anderson, CE Boudreau, E Martinez-Ledesma, E Kocakavuk, ... Cancer cell 37 (2), 243-257. e7, 2020 | 18* | 2020 |
| Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma Y Piao, V Henry, N Tiao, SY Park, J Martinez-Ledesma, JW Dong, ... Oncotarget 8 (57), 96970, 2017 | 13 | 2017 |
| Prognostic relevance of tumor purity and interaction with MGMT methylation in glioblastoma ES Heuling, F Knab, J Radke, E Eskilsson, E Martinez-Ledesma, A Koch, ... Molecular Cancer Research 15 (5), 532-540, 2017 | 13* | 2017 |
| Integration and comparison of different genomic data for outcome prediction in cancer H Gómez-Rueda, E Martínez-Ledesma, A Martínez-Torteya, ... BioData mining 8 (1), 1-12, 2015 | 11 | 2015 |
| Revealing protein networks and gene-drug connectivity in cancer from direct information XL Jiang, E Martinez-Ledesma, F Morcos Scientific reports 7 (1), 1-13, 2017 | 10 | 2017 |
| EGFR amplification induces increased DNA damage response and renders selective sensitivity to Talazoparib (PARP inhibitor) in glioblastoma S Wu, F Gao, S Zheng, C Zhang, E Martinez-Ledesma, R Ezhilarasan, ... Clinical Cancer Research 26 (6), 1395-1407, 2020 | 9* | 2020 |
Victor Trevino (Víctor Manuel Treviño...Bioinformatics, Tecnológico de Monterrey, Escuela de Medicinatec.mx üzerinde doğrulanmış e-posta adresine sahip
